SB
Stephane Bancel
Chief Executive OfficerDirector

Stephane Bancel insider trades: Moderna (MRNA) stock buys and sales

Chief Executive Officer, Moderna Last trade Aug 5, 2026 296 Form 4 filings
$28.7M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
404
Open-market trades
since 2011
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephane reports to the SEC

Open-market buys and sales

404 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 5, 2026MRNA↓ Sell$28.7M
Mar 3, 2025MRNA↑ Buy$5.0M
Feb 16, 2024MRNA↓ Sell$2.3M
Jun 28, 2023MRNA↓ Sell$3.3M
Jun 22, 2023MRNA↓ Sell$9.7M
Jun 15, 2023MRNA↓ Sell$10.2M
Jun 8, 2023MRNA↓ Sell$10.0M
Jun 1, 2023MRNA↓ Sell$10.2M
May 25, 2023MRNA↓ Sell$10.4M
May 18, 2023MRNA↓ Sell$10.0M
May 11, 2023MRNA↓ Sell$10.4M
May 4, 2023MRNA↓ Sell$10.7M
Apr 27, 2023MRNA↓ Sell$10.5M
Apr 20, 2023MRNA↓ Sell$11.4M
Apr 13, 2023MRNA↓ Sell$12.7M
Apr 6, 2023MRNA↓ Sell$12.5M
Mar 30, 2023MRNA↓ Sell$11.9M
Mar 23, 2023MRNA↓ Sell$12.0M
Mar 16, 2023MRNA↓ Sell$12.0M
Mar 9, 2023MRNA↓ Sell$11.2M
Mar 2, 2023MRNA↓ Sell$10.9M
Feb 23, 2023MRNA↓ Sell$12.2M
Feb 16, 2023MRNA↓ Sell$13.9M
Feb 9, 2023MRNA↓ Sell$13.3M
Feb 2, 2023MRNA↓ Sell$13.8M
Jan 26, 2023MRNA↓ Sell$15.3M
Jan 19, 2023MRNA↓ Sell$15.6M
Jan 12, 2023MRNA↓ Sell$14.8M
Jan 5, 2023MRNA↓ Sell$14.1M
Dec 29, 2022MRNA↓ Sell$14.3M
Dec 29, 2022MRNA↓ Sell$1.8M
Dec 22, 2022MRNA↓ Sell$16.5M
Dec 22, 2022MRNA↓ Sell$2.1M
Dec 15, 2022MRNA↓ Sell$16.7M
Dec 15, 2022MRNA↓ Sell$2.1M
Dec 8, 2022MRNA↓ Sell$14.4M
Dec 8, 2022MRNA↓ Sell$1.8M
Dec 1, 2022MRNA↓ Sell$14.1M
Dec 1, 2022MRNA↓ Sell$1.7M
Nov 25, 2022MRNA↓ Sell$7.0M
Nov 25, 2022MRNA↓ Sell$1.8M
Nov 23, 2022MRNA↓ Sell$7.0M
Nov 17, 2022MRNA↓ Sell$14.7M
Nov 17, 2022MRNA↓ Sell$1.8M
Nov 10, 2022MRNA↓ Sell$13.3M
Nov 10, 2022MRNA↓ Sell$1.6M
Nov 3, 2022MRNA↓ Sell$12.0M
Nov 3, 2022MRNA↓ Sell$1.4M
Oct 27, 2022MRNA↓ Sell$11.4M
Oct 27, 2022MRNA↓ Sell$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MRNA insiders

Open-market trades in the last 12 months

About Stephane Bancel's insider trades

Stephane Bancel is Chief Executive Officer at Moderna (MRNA). Since Sep 12, 2011, Stephane has reported 5 open-market purchases worth $5.2M and 399 sales worth $1.22B on SEC Form 4. In the last 12 months: 1 sale ($28.7M).

Their filings also include gifts (105 filings), option exercises (61 filings), grants and awards (19 filings), other transactions (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.